首页> 美国卫生研究院文献>Neuro-Oncology >GERM-04. MANAGEMENT OF CNS GERM CELL TUMORS: EXPERIENCE FROM SUN YAT-SEN UNIVERSITY CANCER CENTER
【2h】

GERM-04. MANAGEMENT OF CNS GERM CELL TUMORS: EXPERIENCE FROM SUN YAT-SEN UNIVERSITY CANCER CENTER

机译:GERM-04。中枢神经系统生殖细胞肿瘤的管理:中山大学肿瘤防治中心的经验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Primary CNS germ cell tumors (CNS-GCTs) are a group of heterogeneous tumors, and comparative higher incidence in Asian countries. Here we present our institutional experience for CNS-GCTs treatment. There are 209 CNS-GCTs cases treated at Sun Yat-sen University Cancer Center during last 15 years. The median age of patients was 16 years old (4-69 y-old). The tumors were classified as Germinoma and Nongerminoma germ cell tumors(NG-GCTs), and also secretory sub-type(AFP≥10 ng/dL and/or β-HCG)≥50 IU/L) or non-secretory sub-type(normal level of tumor marker). There were 60 cases received Ventricle-peritoneal shunt (V-P shunt) or endoscopic third ventricle colostomy due to obstructive hydrocephalus. Treatment modality including: comprehensive treatment 84cases (40.2%), ie chemotherapy plus radiation therapy (some cases with chemo-Radio-chemo Sandwich Therapy) with or without surgical intervention; Monotherapy, ie Chemotherapy only:37 (17.7%), Radiotherapy Only:13 (6.2%). Surgery for tumor removal or biopsy:55cases (25.4%), in which 4 cases were failed from initial diagnostic chemotherapy. There were also some patients(about 6%) received Gamma knife radiosurgery. The 5 years overall survival(OS) rate was better for those with comprehensive treatment, compared those with monotherapy cases: 86.5% vs 66.7%. The 5 ys OS rate according tumor markers was also different: Non Secretory Subtype:79.8%,HCG increased Subtype: 92.9%, AFP increased Subtype: 64.8%, and AFP+HCG coincreased Subtype: 75.0%. Conclusion from our institutional experience: Although smaller number of patients need surgical tumor removal, clinical diagnosed CNS-GCT (without histological confirmation) patients may obtain good responses when receiving comprehensive treatments of chemotherapy combined with radiotherapy.
机译:中枢神经系统生殖细胞原发性肿瘤(CNS-GCT)是一组异质性肿瘤,在亚洲国家中发病率相对较高。在这里,我们介绍了中枢神经系统GCT治疗的机构经验。在过去的15年中,中山大学癌症中心共治疗了209例CNS-GCTs病例。患者的中位年龄为16岁(4-69岁)。肿瘤分为生殖细胞瘤和非生殖细胞生殖细胞瘤(NG-GCT),也有分泌亚型(AFP≥10ng / dL和/或β-HCG)≥50IU / L或非分泌亚型。 (正常水平的肿瘤标志物)。有60例因梗阻性脑积水接受了心室-腹膜分流(V-P分流)或内镜第三脑室结肠造口术。治疗方式包括:综合治疗84例(40.2%),即化学疗法加放射疗法(某些病例采用化学放射放射化学三明治疗法),有或没有手术干预;单一疗法,即仅化学疗法:37(17.7%),仅放射疗法:13(6.2%)。肿瘤切除或活检手术:55例(25.4%),其中4例因初始诊断性化疗失败。也有一些患者(约6%)接受了伽玛刀放射外科手术。与单药治疗相比,接受综合治疗的患者的5年总生存率更高:86.5%对66.7%。根据肿瘤标志物的5 ys OS率也有所不同:非分泌亚型:79.8%,HCG增加亚型:92.9%,AFP增加亚型:64.8%,AFP + HCG共同增加亚型:75.0%。根据我们的机构经验得出的结论:尽管需要手术切除肿瘤的患者人数较少,但是接受综合化疗和放疗的临床诊断为CNS-GCT(未经组织学确认)的患者可能会获得良好的反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号